Go Deep
Kodiak Sciences Inc.
Kodiak Sciences Inc. Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | -28,314 | -21.9 | 94.26 | 0.86 | 8,726.26 |
| Oct 2026 | -22,384 | -19.4 | 83.42 | 0.86 | 7,699.29 |
| Oct 2026 | -26,339 | -21.0 | 90.65 | 0.86 | 8,367.97 |
| Oct 2026 | -25,006 | -20.5 | 88.21 | 0.86 | 8,121.81 |
| Oct 2026 | -28,157 | -21.8 | 93.97 | 0.86 | 8,661.48 |
| Oct 2026 | -29,068 | -22.2 | 95.64 | 0.86 | 8,815.08 |
| Oct 2026 | -26,114 | -20.9 | 90.24 | 0.86 | 8,296.75 |
| Oct 2026 | -25,022 | -20.5 | 88.24 | 0.86 | 8,096.84 |
Kodiak Sciences Inc. Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 0.0 |
| Net Profit | -65,643,000.0 | -58,158,000.0 | -56,736,000.0 | -61,457,000.0 |
| EPS | -1.1 | -0.9 | -1.0 | -1.2 |
Kodiak Sciences Inc. Revenue & Profit: Last 4 Years
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 0.0 |
| Net Profit | -229,967,000.0 | -176,207,000.0 | -260,491,000.0 | -333,823,000.0 |
| EPS | -4.3 | -3.4 | -5.0 | -6.4 |
Kodiak Sciences Inc. Balance Sheet
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Total Assets | 351,533,000.0 | 335,578,000.0 | 479,372,000.0 | 666,628,000.0 | — |
| Total Liabilities | 194,150,000.0 | 185,290,000.0 | 213,591,000.0 | 230,461,000.0 | — |
| Total Equity | 157,383,000.0 | 150,288,000.0 | 265,781,000.0 | 436,167,000.0 | — |
Owes vs Owns
Kodiak Sciences Inc. owed $0.76 for every $1 it owned in Jun 2026, up from $0.35 in Dec 2022.
| Period | Jun 2026 | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|---|
| Owes vs Owns | 0.76× | 0.55× | 0.55× | 0.45× | 0.35× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Kodiak Sciences Inc. Assets & Liabilities Breakdown (USD millions)
What it owns — Dec 2025
Cash & short-term investments 59.7%Fixed assets (tangible) 34.7%Other assets 5.6%
How it's funded — Dec 2025
Short-term debt 3.4%Long-term debt 13.4%Payables 3.7%Other liabilities 34.7%Shareholders' equity 44.8%
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 209.9 | 168.1 | 285.5 | 478.9 |
| Receivables | 0.0 | 0.0 | 0.0 | 0.0 |
| Inventory | 0.0 | 0.0 | 0.0 | 0.0 |
| Fixed assets (tangible) | 121.9 | 148.7 | 175.0 | 115.8 |
| Intangible assets | 0.0 | 0.0 | 0.0 | 0.0 |
| Long-term investments | 0.0 | 0.0 | 0.0 | 0.0 |
| Other assets | 19.8 | 18.8 | 18.8 | 71.9 |
| Liabilities & equity | ||||
| Short-term debt | 12.1 | 10.6 | 9.8 | 9.9 |
| Long-term debt | 47.1 | 59.7 | 71.9 | 77.8 |
| Payables | 12.9 | 3.9 | 13.6 | 9.1 |
| Other liabilities | 122.1 | 111.0 | 118.4 | 133.6 |
| Shareholders' equity | 157.4 | 150.3 | 265.8 | 436.2 |
| Net tangible assets | 157.4 | 150.3 | 265.8 | 436.2 |
Kodiak Sciences Inc. Cash Flow
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Operating Activities | -136,008,000.0 | -117,319,000.0 | -154,183,000.0 | -206,459,000.0 | — |
| Investing Activities | -506,000.0 | -755,000.0 | 249,226,000.0 | -336,513,000.0 | — |
| Financing Activities | 178,302,000.0 | 501,000.0 | 31,000.0 | 1,895,000.0 | — |